Skip to main content
Clinical Trials/NCT06681961
NCT06681961CompletedNot Applicable

The Therapeutic Effects of a Dynamics Closed Kinetic Chain Exercise Combination With Hip Adduction in Patients With Patellofemoral Pain Syndrome

China Medical University Hospital1 site in 1 country30 target enrollmentStarted: November 27, 2017Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
30
Locations
1
Primary Endpoint
Amplitudes of muscle activation (unit: %MVC)

Study Overview

Brief Summary

An imbalance in the activation and onset time of the vastus medialis oblique (VMO) and vastus lateralis (VL) muscles may be one of the primary causes of PFPS. Several studies have discussed various exercise methods believed to selectively contract the (VMO) muscle for treating patellofemoral pain syndrome. VMO activity is higher during static closed-chain tasks combined with hip adduction, indicating that performing hip adduction exercises may selectively strengthen the VMO muscle.

Detailed Description

Patellofemoral pain syndrome (PFPS) poses challenges in motor control and pain management, especially regarding balanced muscle activation of the vastus medialis oblique (VMO) and vastus lateralis (VL). This study introduces a home-based PFPS rehabilitation approach involving a squat exercise program with hip adduction, examining its effects on motor control and clinical outcomes. Thirty PFPS participants were randomly assigned to conventional squatting (SQU) or squatting with hip adduction (SQU-HA) groups. Participants performed exercises five days a week for 8 weeks, with pre- and post-assessments capturing clinical measures and motor control indicators using electromyography (EMG). This home-based program, integrating hip adduction into squats, enhances motor control, reduces knee stress, and improves daily function, ensuring continued care post-pandemic.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Masking Description

This was a prospective, randomized-controlled trial.

Eligibility Criteria

Ages
20 Years to 50 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Age 20-50 years.
  • •Pain around the patella at least two of the following activities¬-standing up after prolonged sitting, going up and down the stairs, running, jumping, squatting, kneeling, and high-angle knee flexion for a long time.
  • •Knee joint pain for ≥3 months.
  • •Pain level of ≥ 30 mm on a 100-mm visual analog scale (VAS).

Exclusion Criteria

  • •Had a history of patellar subluxation, dislocation, or knee surgery.
  • •Had central or peripheral neurological pathology.
  • •Had an obvious knee joint deformity or lower extremity malalignment.
  • •Experienced severe knee joint pain (VAS) score > 80 mm), or received nonsteroidal anti-inflammatory drugs, injections, or physical therapy within the past 3 months.

Arms & Interventions

squatting with hip adduction (SQU-HA) group

Experimental

The participants stood equally on both legs on the floor with their feet shoulder-width apart and angled outward at 20°-30°. After a warm-up, the participants performed 45° squats with squeezing a Swiss ball of 18-cm diameter at a slow speed of 2 s for flexion and extension from the standing posture by using a commercial metronome. The squatting with knee flexion from 0° to 45° was the safest for people with PFPS.

Intervention: squatting with hip adduction (SQU-HA) group (Other)

squatting (SQU) group

Other

The participants stood equally on both legs on the floor with their feet shoulder-width apart and angled outward at 20°-30°. After a warm-up, the participants performed 45° squats at a slow speed of 2 s for flexion and extension from the standing posture by using a commercial metronome. The squatting with knee flexion from 0° to 45° was the safest for people with PFPS.

Intervention: squatting with hip adduction (SQU-HA) group (Other)

Outcomes

Primary Outcomes

Amplitudes of muscle activation (unit: %MVC)

Time Frame: pre-intervention and after 8-week intervention

represented the mean RMSs for each muscle which was normalized by the maximal voluntary contractions (MVC).

VMO/VL ratio

Time Frame: pre-intervention and after 8-week intervention

represents the amplitude ratio of VMO relative to VL.

Onset time (unit: msec)

Time Frame: pre-intervention and after 8-week intervention

at 200 ms before the beginning of the trial, as the baseline, the onset of EMG activation was identified as the point at which the EMG amplitude was more than three standard deviations from the baseline level for at least 25 ms.

VMO - VL (unit: msec)

Time Frame: pre-intervention and after 8-week intervention

represented the onset time differences of VMO relative to VL, with a positive (negative) value indicating a delayed (early) onset time of VMO relative to VL.

Q angle (unit: degree)

Time Frame: pre-intervention and after 8-week intervention

The angle was calculated with the intersection formed by two lines crossing the center of the patella. The first line went from the ASIS to the center of the patella and the second from the anterior tuberosity of the tibia to the center of the patella.

The visual analogue scale (VAS) (unit: mm)

Time Frame: pre-intervention and after 8-week intervention

VAS was used to assess pain severity. The participants were asked to mark their pain levels on a 100-mm ruler (ranging from 0 = "no pain" to 100 = "unbearable pain") before and after the exercise program.

patellofemoral pain severity scale (PSS) (unit: score)

Time Frame: pre-intervention and after 8-week intervention

PSS was used to measure PFPS associated with functional activities over the past week. The scale comprises 10 items, including climbing/descending stairs, squatting, walking, jogging, running/sprinting, participating in a sport, sitting with knees bent (for 20 min), kneeling, resting, and following an activity. The maximum score was 100 points. The participants rated their pain on a 100-mm VAS, ranging from 0 = "no pain" to 100 = "unbearable pain".

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Wei-Hsien Hong

China Medical University

China Medical University Hospital

Study Sites (1)

Loading locations...

Similar Trials